Search results
...Enhances Mutation-Independent Retinal Gene Therapy Programs with Appointment of Allen C. Ho, MD,...
KTLA-TV Los Angeles· 4 days agoNanoscope Therapeutics, Inc., a clinical-stage biotechnology company developing gene therapies for retinal degenerative diseases, announced today the appointment of Allen ...
Phase 2 RIZE Study Sub-Analyses to be Presented at the 2024 Pediatric Endocrine Society Annual...
Morningstar· 6 days agoRezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or the “Company”), a clinical-stage biopharmaceutical company committed to developing novel, transformative... Grand Chicago Riverwalk ...
Medicure Receives US FDA Fast Track Designation for MC-1 for PNPO Deficiency
Morningstar· 5 days agoFood and Drug Administration (FDA) has granted Fast Track designation for MC-1, an...) deficiency. Fast Track designation is intended to facilitate the development and expedite the review of ...
Soligenix Extends Patent Protection for its Filovirus Vaccine Platform to the United Kingdom and...
Morningstar· 4 days agoSoligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases ...
Biodexa shares rally 126% on rapamycin licensing deal (NASDAQ:BDRX)
Seeking Alpha· 3 days agoBiodexa (BDRX) stock soared 126% Friday after the company announced an exclusive icensing deal to...
KKR to acquire Swedish pharma firm Immedica (NYSE:KKR)
Seeking Alpha· 6 days agoInvestment firm KKR acquires Immedica Pharma, a Stockholm-based pharmaceutical company specializing in rare diseases and specialty care products.
Deverra Therapeutics Granted FDA Fast Track Designation for DVX101
Digital Journal· 4 days agoDesignation Validates Preliminary Data and Supports Accelerated Drug Development SEATTLE, WA / ACCESSWIRE / April 24, 2024 / Deverra Therapeutics, Inc., a clinical-stage biotechnology ...
Walgreens Launches Gene and Cell Services as Part of Newly Integrated Walgreens Specialty Pharmacy...
Morningstar· 4 days agoWalgreens Launches Gene and Cell Services as Part of Newly Integrated Walgreens Specialty Pharmacy Business Walgreens Specialty Pharmacy combines existing specialty assets, fully integrates ...
CPR Cell Phone Repair Expands in California with New Store in Temecula
Digital Journal· 5 days ago(KSBI) Announces First Quarter 2023 Financial Results and Cash Dividend Laxxon Medical to Participate in the World Orphan Drug Congress USA 2024 HHG Capital ...
SpringWorks Therapeutics Announces Abstracts Accepted for Presentation at the 2024 American Society...
Morningstar· 5 days ago– Results from Phase 2b ReNeu trial of mirdametinib in NF1-PN accepted for oral presentation – – Additional data from the Phase 3 DeFi trial of OGSIVEO® (nirogacestat) in adults with desmoid tumors also accepted for presentations at ASCO – STAMFORD